NAP6 – deaths, cardiac arrests, profound hypotension and outcomes Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.

Slides:



Advertisements
Similar presentations
Heart Disease.
Advertisements

SEPSIS KILLS program Paediatric Inpatients
ACLS Medications.
European Resuscitation Council
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
ACLS ALGORITHMS.
Anaphylaxis By : O. Ahmadi, MD. Professor Assistant of Esfahan medical School, Emergency Department of Al-Zahra Hospital.
The Vexing Problem of Vasoplegia
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Amiodarone Use in Cardiac Surgical Resuscitation
Bradycardia Risk of asystole? History of asystole Mobitz II AV block Any pause  3 s Complete heart block, wide QRS Adverse signs? Clinical evidence of.
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
RELATIVE TOXICITY OF CITALOPRAM AND OTHER SSRIs IN OVERDOSE GK Isbister 1,2, IM Whyte 1,2, AH Dawson 1,2 1 Department of Clinical Toxicology, Newcastle.
2003 Prehospital Patient Care Protocols VII. Pediatric Protocols Old Dominion Emergency Medical Services Alliance.
Anaphylaxis: Rapid recognition and treatment Miha Mežnar MD Medical intensive care unit General hospital Celje, Slovenia.
ACLS Past, Present & Future Dr FT Lee A&E, PMH 2004
Diagnosis and Management of Shock Dr. Anas Khan Consultant, EM MBBS, MHA, ArBEM.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
ARRHYTHMIA. Disturbance of cardiac rythumn Anatomy of the conducting system.
Intralipid.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
Special Circumstances Workshop Anaphylaxis. By the end of this session the candidate will: Understand the approach to the patient with anaphylaxis Recognise.
ELITE - II Study Design  60 yrs; NYHA II - IV; EF  40 % ACEI naive or  7 days in 3 months prior to entry Standard Rx ( ± Dig / Diuretics ), ß - blocker.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Early CPR matters; what about early defibrillation? First important to understand different cardiac arrest rhythms: Ventricular fibrillation – heart rhythm.
NAP6 Perioperative Anaphylaxis The Royal College of Anaesthetists’ 6 th National Audit Project Starting on 5 th February 2016.
 Using conventional ionic contrast agents, total adverse reactions can be expected with a frequency of ~5-8%  Adverse reactions from intravascular contrast.
Cardiac Arrest: Audit of practice in ICU from 1 st August 2014 to 31 st January 2015 Dr C Hickey and Dr Elizabeth Little.
Anaphylaxis.
Hyponatremia. Definition Serum [Na] < 135 meq/L Serum [Na] < 135 meq/L - incidence is 1%-4% Serum [Na] < 130meq/L - incidence is 15%-30% (represents a.
Manufacturer: Merck FDA Approval Date: December 15, 2015
Cardiopulmonary resuscitation
Resuscitation in special circumstances workshop Anaphylaxis
Anaphylactic Shock On The Cath Table: Bivalirudin To Blame?
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
CODE BLUE MANAGEMENT DRUG THERAPY
A new preoperative Severity Scoring System For Acute Cholecystitis
NAP6 Perioperative Anaphylaxis
PEA arrest: Chest compressions aren’t enough
AAGA during general anaesthesia in intensive care
Advanced Life Support.
The European Society of Cardiology Presented by Dr. Saman Rasoul
Capnography in Cardiac Arrest NO TRACE = WRONG PLACE
Department of OUTCOMES RESEARCH
Overview and Key Findings Prof Nigel Harper Clinical Lead, NAP6
CLINICAL FEATURES Dr K-L Kong, MD MBBS FRCA, Consultant Anaesthetist Dr Surendra Karanam, BSc MBBS MRCP FRCP FRCPath, Consultant Immunologist.
Immediate Management Prof Nigel Harper Clinical Lead, NAP6
Obstetrics Nuala Lucas OAA
Method Two month data collection period (Feb-Mar 2004)
Antibiotics Shuaib Nasser Cambridge University Hospitals NHS Foundation Trust NAP6 Steering Committee member.
Percutaneous Mechanical Circulatory Support Devices
Chlorhexidine Tomaz Garcez Consultant Immunology
NAP6 Paediatric cases Mark Thomas Paediatric Anaesthetist Great Ormond Street Hospital, London Council member, Association of Paedaitrc Anaesthetists.
Dr. PJ Devereaux on behalf of POISE Investigators
PROCAMIO Trial design: Patients with hemodynamically stable wide complex monomorphic tachycardia were randomized 1:1 to either intravenous procainamide.
Airway management Second cause of mortality in anaesthesia in 1996 in France = 1/3 of the anaesthesia mortality. 600 deaths in UK in to 30% of.
Investigations: The NAP6 Data Prof
NAP6 – the independent/private sector m Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
Infections in Surgical Patients: Intensive Care Unit
What We Already Know Reported as a cause of anaphylaxis since the 1960s Cardiovascular collapse is the commonest presentation Allergic reactions can be.
Dr. PJ Devereaux on behalf of POISE Investigators
The Patient Experience Mr John Hitchman RCoA Lay Representative
Clonidine in Patients Having Noncardiac Surgery
5 phases Baseline survey of anaesthetists perspectives/experiences
Activity Survey Harriet Kemp Research & Audit Federation of Trainees
Claudio Sandroni a,., Giorgia Ferro a,
May 2019 progress report on key performance indicators at RiverCom
Anaphylaxis: Rapid recognition and treatment
9. Anaphylaxis Journal of Allergy and Clinical Immunology
Dr Donal O’Donoghue National Clinical Director for Kidney Care
Presentation transcript:

NAP6 – deaths, cardiac arrests, profound hypotension and outcomes Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath

What we already knew Death from anaphylaxis usually <1 hr 4% commonly quoted for peri-op hypersensitivity (Grade 1-4) 0% (<1.4%) 0/264 Western Australia 2000-9 (Grade 1-5) 4% France 2018 (NMBA Grade 1-5) Asthma increased risk (community) Raised baseline MCT (envenomation)

What we already knew Cardiac arrest Elderly increased risk <5 mins for drug induced Elderly increased risk Sadleir – no increased ‘risk’ if surgery completed in Grade 3(or 4) (167 pts)

DEATHS Deaths 10/ 266 (3.8%) grade 3-5 cases 1 in 313,000 procedures but we reviewed all deaths …… so could be 2.2% and only Grade 3-5 1 in 313,000 procedures 1 in 239,000 GAs NO ERRORS

Deaths 6 female/4 male All age >45; 5 aged >65 (25% >65, 50% >45 in Activity survey) 6 ASA3, 2 ASA 4 (<2% ASA 4-5, 77% 1-2 in Activity survey) Obesity (21% obese in Activity survey) 1 normal weight, 4 overweight, 1 obese, 4 morbidly obese 5 emergencies 3 cardiac operations (1% in Activity survey)

Clinical features

Clinical features

Deaths All arrests PEA +/- bradycardia: no other arrythmias Prolonged resuscitation 5 survived resus median >39 mins, all >25 mins ECMO, PCI 4 died of MOFS

Deaths Onset Adrenaline median 5mg (2-13) Delay in recognition =1 7 = <5 mins 3 = <10 mins Delay in recognition =1 Prompt treatment = all Complete – ALS Adrenaline median 5mg (2-13) 1 glucagon 1 vasopressin 50% steroids 50% antihistamines Modest fluids….1.5L

Deaths

Beta blockade as a risk for death Only 1 patient received glucagon At 65 minutes

-old age -cardiac disease -obesity – but not asthma (no atopy either)

Culprits Antibiotics and NMBAs – but not only

Deaths All had MCTs done None had sIgEs None referred to or discussed with allergy clinic None had PM details

Cardiac arrest 40 cases (15%)(including 9 of the deaths)

Clinical features of 37 cardiac arrests

Clinical features of 37 cardiac arrests

Cardiac arrest 40 cases (including 9 of the deaths) Median duration CPR 8 minutes (survivors) (vs 39 mins deaths) PEA 85% VF 10% (all presented with tachycardia) Asystole 5% Preceding hypotension 37.5% Preceding arrythmia 15% (4 brady, 2 VT) 31 survived (77.5%)

Cardiac arrest Not especially unfit Nothing special about the drugs administered More patients on ACEI No evidence of adrenaline-induced complications (arrythmia, ischaemia)

Cardiac arrest Average 5mg adrenaline 91% went to ICU – 90% level 3 61% needed vasopressor infusions 6% bronchodilators Typically 2 days in ICU No recrudescence 1/3 patients reported longer term harm

Profound hypotension Commonest presenting feature Universal in Grade 3-5 peri-op anaphylaxis 74% <60mmHg 31% <50mmHg ‘without cardiac arrest’

Profound hypotension Cases CPR Cardiac arrest 15% 100% Unrecordable BP 21% 50% BP <50mmHg 22% 9% BP 51-60mmHg 20% 2%

Profound hypotension With invasive BP monitoring 50mmHg is a ‘pulseless state’ NIBP overreads in hypotension …….So just when are you going to start CPR?

Anaphylaxis management -good -except CPR

Outcomes

Outcomes

Outcomes

Recommendations

Recommendations

Recommendations

Summary Deaths Cardiac arrest Profound hypotension Outcomes 3.8%, cardiac, elderly, beta-blocker, ACEI, obese, prolonged resus Cardiac arrest 15%, ACEI, younger/fitter, well managed, brief CPR, good outcomes Profound hypotension 50%, delayed or no CPR, some poor outcomes Outcomes 1/3 altered outcomes, some major, anxiety, but overall good